Neovascularization of the amniotic membrane as a biological immune barrier.
The clinical application of islet transplantation is limited due to the limited source and the morbidity of systemic immunosuppression to prevent rejection. The two problems can be solved by using encapsulated islets. We have used amniotic membranes as biocompatible natural immune barriers. The objective of this study was to assess the revascularization of the membrane, which is necessary to ensure islet viability when the membrane is used for islet encapsulation. The amniotic membranes, obtained from full-term pregnant female dogs, were molded to form macrocapsules, which were implanted in the peritoneal cavity. The capsules were removed after 3, 10, 15, and 30 days and examined histopathologically using hematoxylin and eosin and by immunohistochemistry for neovascularization using factor VIII to detect angiogenesis. Upon histopathological examination, all specimens showed localized, moderate inflammation and congested blood vessels with no thrombosis or rejection. There was a mild degree of fibroblast proliferation starting from day 10 to day 30. Immunohistochemical staining revealed that the number of blood vessels was 7, 11, 13, 10 per high-power microscopic field on days 3, 10, 15, and 30, respectively. We concluded from this study that implanted amniotic sac capsules were vascularized within the omental tissue from day 10 on with significant blood vessel formation starting on day 3 by immunohistochemical study.
Mahgoub
M A
MA
Pancreatic Islet Transplantation and Diabetes Research Unit, Ain Shams University Hospital, Cairo, Egypt. Pitro@link.net
Ammar
A
A
Fayez
M
M
Edris
A
A
Hazem
A
A
Akl
M
M
Hammam
O
O
D000650:Amnion / Q000098:blood supply* / Q000166:cytology / Q000276:immunology*; D000818:Animals; D002214:Capsules; D018929:Cell Culture Techniques; D002470:Cell Survival; D004285:Dogs; D005260:Female; D007515:Islets of Langerhans / Q000166:cytology*; D016381:Islets of Langerhans Transplantation / Q000379:methods; D007700:Kinetics; D018919:Neovascularization, Physiologic / Q000502:physiology*; D011247:Pregnancy; D014183:Transplantation, Heterologous
D002214:Capsules